Clinical Trial Update: Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating autologous adipose-derived mesenchymal stem cells for safety and efficacy in adults with atrophic scars. The study is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrophic Scar

Drugs mentioned

• Autologous Adipose-derived Mesenchymal Stem Cells Therapy

Snippet

Sponsor: CellinCells | Conditions: Atrophic Scar | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING